{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:27:40Z","timestamp":1791613660416,"version":"4.3.4"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To understand neutrophil impairment in the progression from MGUS through active MM, we investigated the function of mature, high-density neutrophils (HDNs), isolated from peripheral blood. In 7 MM, 3 MGUS and 3 healthy subjects by gene expression profile, we identified a total of 551 upregulated and 343 downregulated genes in MM-HDN, involved in chemokine signaling pathway and FC-gamma receptor mediated phagocytosis conveying in the activation of STAT proteins. In a series of 60 newly diagnosed MM and 30 MGUS patients, by flow-cytometry we found that HDN from MM, and to a lesser extend MGUS, had an up-regulation of the inducible Fc\u03b3RI (also known as CD64) and a down-regulation of the constitutive Fc\u03b3RIIIa (also known as CD16) together with a reduced phagocytic activity and oxidative burst, associated to increased immune-suppression that could be reverted by arginase inhibitors in co-culture with lymphocytes. In 43 consecutive newly-diagnosed MM patients, who received first-line treatment based on bortezomib, thalidomide and dexamethasone, high CD64 could identify at diagnosis patients with inferior median overall survival (39.5 versus 86.7 months, p\u2009=\u20090.04). Thus, HDNs are significantly different among healthy, MGUS and MM subjects. In both MGUS and MM neutrophils may play a role in supporting both the increased susceptibility to infection and the immunological dysfunction that leads to tumor progression.<\/jats:p>","DOI":"10.1038\/s41598-020-58859-x","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T11:04:48Z","timestamp":1580987088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling"],"prefix":"10.1038","volume":"10","author":[{"given":"A.","family":"Romano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. L.","family":"Parrinello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Simeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"La Cava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bellofiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Giallongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Camiolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"D\u2019Auria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Larocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Cambria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"La Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tibullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. A.","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Conticello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Musto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Di Raimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"key":"58859_CR1","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","volume":"117","author":"M Dimopoulos","year":"2011","unstructured":"Dimopoulos, M. et al. Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. Blood 117, 4701\u20134705 (2011).","journal-title":"Blood"},{"key":"58859_CR2","doi-asserted-by":"publisher","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren, O. et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood 113, 5412\u20135417 (2009).","journal-title":"Blood"},{"key":"58859_CR3","doi-asserted-by":"publisher","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","volume":"113","author":"BM Weiss","year":"2009","unstructured":"Weiss, B. M., Abadie, J., Verma, P., Howard, R. S. & Kuehl, W. M. A monoclonal gammopathy precedes multiple myeloma in most patients. Blood 113, 5418\u20135422 (2009).","journal-title":"Blood"},{"key":"58859_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7326\/0003-4819-96-1-47","volume":"96","author":"DG Savage","year":"1982","unstructured":"Savage, D. G., Lindenbaum, J. & Garrett, T. J. Biphasic pattern of bacterial infection in multiple myeloma. Ann. Intern. Med. 96, 47\u201350 (1982).","journal-title":"Ann. Intern. Med."},{"key":"58859_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/ejh.13066","volume":"101","author":"R Sorrig","year":"2018","unstructured":"Sorrig, R., Klausen, T. W., Salomo, M., Vangsted, A. & Gimsing, P. Risk factors for blood stream infections in multiple myeloma: A population-based study of 1154 patients in Denmark. Eur. J. Haematol. 101, 21\u201327 (2018).","journal-title":"Eur. J. Haematol."},{"key":"58859_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3324\/haematol.2011.054015","volume":"97","author":"SY Kristinsson","year":"2012","unstructured":"Kristinsson, S. Y. et al. Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study. Haematologica 97, 854\u2013858 (2012).","journal-title":"Haematologica"},{"key":"58859_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1600-0609.1998.tb01075.x","volume":"61","author":"H Gregersen","year":"1998","unstructured":"Gregersen, H. et al. The risk of bacteremia in patients with monoclonal gammopathy of undetermined significance. Eur. J. haematology 61, 140\u2013144 (1998).","journal-title":"Eur. J. haematology"},{"key":"58859_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-2141.2007.06705.x","volume":"138","author":"G Pratt","year":"2007","unstructured":"Pratt, G., Goodyear, O. & Moss, P. Immunodeficiency and immunotherapy in multiple myeloma. Br. J. haematology 138, 563\u2013579 (2007).","journal-title":"Br. J. haematology"},{"key":"58859_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/CVI.00021-11","volume":"18","author":"J Karlsson","year":"2011","unstructured":"Karlsson, J. et al. Comparative study of immune status to infectious agents in elderly patients with multiple myeloma, Waldenstrom\u2019s macroglobulinemia, and monoclonal gammopathy of undetermined significance. Clin. vaccine immunology: CVI 18, 969\u2013977 (2011).","journal-title":"Clin. vaccine immunology: CVI"},{"key":"58859_CR10","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.1200\/JCO.2005.03.2086","volume":"23","author":"BM Augustson","year":"2005","unstructured":"Augustson, B. M. et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002\u2013Medical Research Council Adult Leukaemia Working Party. J. Clin. oncology: Off. J. Am. Soc. Clin. Oncol. 23, 9219\u20139226 (2005).","journal-title":"J. Clin. oncology: Off. J. Am. Soc. Clin. Oncol."},{"key":"58859_CR11","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/jcp.48.3.260","volume":"48","author":"RM Hargreaves","year":"1995","unstructured":"Hargreaves, R. M. et al. Immunological factors and risk of infection in plateau phase myeloma. J. Clin. Pathol. 48, 260\u2013266 (1995).","journal-title":"J. Clin. Pathol."},{"key":"58859_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fimmu.2014.00257","volume":"5","author":"SM Tete","year":"2014","unstructured":"Tete, S. M., Bijl, M., Sahota, S. S. & Bos, N. A. Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma. Front. immunology 5, 257 (2014).","journal-title":"Front. immunology"},{"key":"58859_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00281-013-0374-8","volume":"35","author":"S Jaillon","year":"2013","unstructured":"Jaillon, S. et al. Neutrophils in innate and adaptive immunity. Semin. Immunopathol. 35, 377\u2013394 (2013).","journal-title":"Semin. Immunopathol."},{"key":"58859_CR14","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1182\/blood-2016-10-744441","volume":"129","author":"M Vono","year":"2017","unstructured":"Vono, M. et al. Neutrophils acquire the capacity for antigen presentation to memory CD4(+) T cells in vitro and ex vivo. Blood 129, 1991\u20132001 (2017).","journal-title":"Blood"},{"key":"58859_CR15","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1189\/jlb.1MR1014-502R","volume":"98","author":"A Takashima","year":"2015","unstructured":"Takashima, A. & Yao, Y. Neutrophil plasticity: acquisition of phenotype and functionality of antigen-presenting cell. J. Leukoc. Biol. 98, 489\u2013496 (2015).","journal-title":"J. Leukoc. Biol."},{"key":"58859_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-017-0019-6","volume":"7","author":"A Romano","year":"2017","unstructured":"Romano, A. et al. The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents. Blood Cancer J. 7, 649 (2017).","journal-title":"Blood Cancer J."},{"key":"58859_CR17","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1007\/s00277-015-2462-4","volume":"94","author":"A Romano","year":"2015","unstructured":"Romano, A. et al. Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents. Ann. Hematol. 94, 1875\u20131883 (2015).","journal-title":"Ann. Hematol."},{"key":"58859_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000490488","volume":"140","author":"GW Lee","year":"2018","unstructured":"Lee, G. W. et al. The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma. Acta Haematol. 140, 146\u2013156 (2018).","journal-title":"Acta Haematol."},{"key":"58859_CR19","doi-asserted-by":"publisher","first-page":"e13359","DOI":"10.1111\/ctr.13359","volume":"32","author":"S Solmaz Medeni","year":"2018","unstructured":"Solmaz Medeni, S. et al. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation? Clin. Transpl. 32, e13359 (2018).","journal-title":"Clin. Transpl."},{"key":"58859_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3233\/CBM-170795","volume":"22","author":"X Zhou","year":"2018","unstructured":"Zhou, X. et al. Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving borte- zomib-based therapy for multiple myeloma. Cancer Biomark 22, 43\u201348 (2018).","journal-title":"Cancer Biomark"},{"key":"58859_CR21","doi-asserted-by":"crossref","first-page":"18792","DOI":"10.18632\/oncotarget.13320","volume":"8","author":"L Shi","year":"2017","unstructured":"Shi, L. et al. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma. Oncotarget 8, 18792\u201318801 (2017).","journal-title":"Oncotarget"},{"key":"58859_CR22","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/jcla.22004","volume":"30","author":"S Wongrakpanich","year":"2016","unstructured":"Wongrakpanich, S. et al. The Prognostic Significance of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Patients With Multiple Myeloma. J. Clin. Lab. Anal. 30, 1208\u20131213 (2016).","journal-title":"J. Clin. Lab. Anal."},{"key":"58859_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.imbio.2016.02.001","volume":"222","author":"I Mishalian","year":"2017","unstructured":"Mishalian, I., Granot, Z. & Fridlender, Z. G. The diversity of circulating neutrophils in cancer. Immunobiology 222, 82\u201388 (2017).","journal-title":"Immunobiology"},{"key":"58859_CR24","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1189\/jlb.5MR1216-508R","volume":"102","author":"ME Shaul","year":"2017","unstructured":"Shaul, M. E. & Fridlender, Z. G. Neutrophils as active regulators of the immune system in the tumor microenvironment. J. Leukoc. Biol. 102, 343\u2013349 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"58859_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/imr.12444","volume":"273","author":"LW Treffers","year":"2016","unstructured":"Treffers, L. W., Hiemstra, I. H., Kuijpers, T. W., van den Berg, T. K. & Matlung, H. L. Neutrophils in cancer. Immunological Rev. 273, 312\u2013328 (2016).","journal-title":"Immunological Rev."},{"key":"58859_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nrc.2016.52","volume":"16","author":"SB Coffelt","year":"2016","unstructured":"Coffelt, S. B., Wellenstein, M. D. & de Visser, K. E. Neutrophils in cancer: neutral no more. Nat. reviews. Cancer 16, 431\u2013446 (2016).","journal-title":"Nat. reviews. Cancer"},{"key":"58859_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1600-0609.1976.tb02842.x","volume":"17","author":"H Karle","year":"1976","unstructured":"Karle, H., Hansen, N. E. & Plesner, T. Neutrophil defect in multiple myeloma. Studies on intraneutrophilic lysozyme in multiple myeloma and malignant lymphoma. Scand. J. Haematol. 17, 62\u201370 (1976).","journal-title":"Scand. J. Haematol."},{"key":"58859_CR28","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/14737159.2018.1470929","volume":"18","author":"A Romano","year":"2018","unstructured":"Romano, A. et al. PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy. Expert. Rev. Mol. Diagn. 18, 675\u2013683 (2018).","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"58859_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.it.2019.01.006","volume":"40","author":"F Mollinedo","year":"2019","unstructured":"Mollinedo, F. Neutrophil Degranulation, Plasticity, and Cancer Metastasis. Trends Immunology 40, 228\u2013242 (2019).","journal-title":"Trends Immunology"},{"issue":"2","key":"58859_CR30","doi-asserted-by":"publisher","first-page":"aaf8943","DOI":"10.1126\/sciimmunol.aaf8943","volume":"1","author":"Thomas Condamine","year":"2016","unstructured":"Condamine, T. et al. Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Science immunology, 1 (2016).","journal-title":"Science Immunology"},{"key":"58859_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1189\/jlb.0311177","volume":"91","author":"JI Youn","year":"2012","unstructured":"Youn, J. I., Collazo, M., Shalova, I. N., Biswas, S. K. & Gabrilovich, D. I. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J. Leukoc. Biol. 91, 167\u2013181 (2012).","journal-title":"J. Leukoc. Biol."},{"key":"58859_CR32","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1007\/s00018-013-1286-4","volume":"70","author":"J Pillay","year":"2013","unstructured":"Pillay, J., Tak, T., Kamp, V. M. & Koenderman, L. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences. Cell. Mol. Life Sci. 70, 3813\u20133827 (2013).","journal-title":"Cell. Mol. Life Sci."},{"key":"58859_CR33","doi-asserted-by":"crossref","unstructured":"Giallongo, C. et al. Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC). Oncotarget (2016).","DOI":"10.18632\/oncotarget.7969"},{"key":"58859_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.smim.2017.12.004","volume":"35","author":"J Zhou","year":"2018","unstructured":"Zhou, J., Nefedova, Y., Lei, A. & Gabrilovich, D. Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells. Semin. immunology 35, 19\u201328 (2018).","journal-title":"Semin. immunology"},{"key":"58859_CR35","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.canlet.2015.10.040","volume":"371","author":"IR Ramachandran","year":"2016","unstructured":"Ramachandran, I. R. et al. Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy. Cancer Lett. 371, 117\u2013124 (2016).","journal-title":"Cancer Lett."},{"key":"58859_CR36","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1182\/blood-2012-08-448548","volume":"121","author":"GT Gorgun","year":"2013","unstructured":"Gorgun, G. T. et al. Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans. Blood 121, 2975\u20132987 (2013).","journal-title":"Blood"},{"key":"58859_CR37","doi-asserted-by":"crossref","unstructured":"Mortaz, E., Alipoor, S. D., Adcock, I. M., Mumby, S. & Koenderman, L. Update on Neutrophil Function in Severe Inflammation. Frontiers in Immunology, 9 (2018).","DOI":"10.3389\/fimmu.2018.02171"},{"key":"58859_CR38","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.3390\/ijms20143548","volume":"20","author":"F Puglisi","year":"2019","unstructured":"Puglisi, F. et al. Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy Via STAT3. Int. J. Mol. Sci. 20, 3548 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"58859_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou, Y. et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 10, 1523 (2019).","journal-title":"Nat. Commun."},{"key":"58859_CR40","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4049\/jimmunol.160.2.911","volume":"160","author":"C Bovolenta","year":"1998","unstructured":"Bovolenta, C., Gasperini, S., McDonald, P. P. & Cassatella, M. A. High affinity receptor for IgG (Fc gamma RI\/CD64) gene and STAT protein binding to the IFN-gamma response region (GRR) are regulated differentially in human neutrophils and monocytes by IL-10. J. Immunol. 160, 911\u2013919 (1998).","journal-title":"J. Immunol."},{"key":"58859_CR41","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0014-5793(96)00453-X","volume":"386","author":"C Bovolenta","year":"1996","unstructured":"Bovolenta, C., Gasperini, S. & Cassatella, M. A. Granulocyte colony-stimulating factor induces the binding of STAT1 and STAT3 to the IFNgamma response region within the promoter of the Fc(gamma)RI\/CD64 gene in human neutrophils. FEBS Lett. 386, 239\u2013242 (1996).","journal-title":"FEBS Lett."},{"key":"58859_CR42","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1189\/jlb.1206763","volume":"82","author":"X Hu","year":"2007","unstructured":"Hu, X., Chen, J., Wang, L. & Ivashkiv, L. B. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. J. Leukoc. Biol. 82, 237\u2013243 (2007).","journal-title":"J. Leukoc. Biol."},{"key":"58859_CR43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cellimm.2004.04.006","volume":"228","author":"S Agrawal","year":"2004","unstructured":"Agrawal, S., Reemtsma, K., Bagiella, E., Oluwole, S. F. & Braunstein, N. S. Role of TAP-1 and\/or TAP-2 antigen presentation defects in tumorigenicity of mouse melanoma. Cell Immunol. 228, 130\u2013137 (2004).","journal-title":"Cell Immunol."},{"key":"58859_CR44","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1002\/cncr.11072","volume":"97","author":"VM Lauta","year":"2003","unstructured":"Lauta, V. M. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications. Cancer 97, 2440\u20132452 (2003).","journal-title":"Cancer"},{"key":"58859_CR45","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.coph.2011.06.007","volume":"11","author":"LR Prince","year":"2011","unstructured":"Prince, L. R., Whyte, M. K., Sabroe, I. & Parker, L. C. The role of TLRs in neutrophil activation. Curr. Opin. Pharmacol. 11, 397\u2013403 (2011).","journal-title":"Curr. Opin. Pharmacol."},{"key":"58859_CR46","doi-asserted-by":"publisher","first-page":"24113","DOI":"10.1074\/jbc.M111.235275","volume":"286","author":"C Ehlting","year":"2011","unstructured":"Ehlting, C. et al. Distinct functions of the mitogen-activated protein kinase-activated protein (MAPKAP) kinases MK2 and MK3: MK2 mediates lipopolysaccharide-induced signal transducers and activators of transcription 3 (STAT3) activation by preventing negative regulatory effects of MK3. J. Biol. Chem. 286, 24113\u201324124 (2011).","journal-title":"J. Biol. Chem."},{"key":"58859_CR47","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.4049\/jimmunol.1300058","volume":"192","author":"BR Rosborough","year":"2014","unstructured":"Rosborough, B. R. et al. Cutting edge: Flt3 ligand mediates STAT3-independent expansion but STAT3-dependent activation of myeloid-derived suppressor cells. Journal of immunology (Baltimore, Md.: 1950) 192, 3470\u20133473 (2014).","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"58859_CR48","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1172\/JCI60083","volume":"123","author":"D Vasquez-Dunddel","year":"2013","unstructured":"Vasquez-Dunddel, D. et al. STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients. J. Clin. investigation 123, 1580\u20131589 (2013).","journal-title":"J. Clin. investigation"},{"key":"58859_CR49","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1172\/JCI68189","volume":"123","author":"JD Waight","year":"2013","unstructured":"Waight, J. D. et al. Myeloid-derived suppressor cell development is regulated by a STAT\/IRF-8 axis. J. Clin. investigation 123, 4464\u20134478 (2013).","journal-title":"J. Clin. investigation"},{"key":"58859_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/SLA.0b013e3181bfda1c","volume":"251","author":"V Munera","year":"2010","unstructured":"Munera, V. et al. Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin. Ann. Surg. 251, 120\u2013126 (2010).","journal-title":"Ann. Surg."},{"key":"58859_CR51","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1158\/0008-5472.CAN-11-2772","volume":"72","author":"F Roth","year":"2012","unstructured":"Roth, F. et al. Aptamer-mediated blockade of IL4Ralpha triggers apoptosis of MDSCs and limits tumor progression. Cancer Res. 72, 1373\u20131383 (2012).","journal-title":"Cancer Res."},{"key":"58859_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1959-5","volume":"10","author":"C Giallongo","year":"2019","unstructured":"Giallongo, C. et al. TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma. Cell Death Dis. 10, 704 (2019).","journal-title":"Cell Death Dis."},{"key":"58859_CR53","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","volume":"17","author":"S Kumar","year":"2016","unstructured":"Kumar, S. et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet. Oncol. 17, e328\u2013e346 (2016).","journal-title":"Lancet. Oncol."},{"key":"58859_CR54","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-0716-0154-9_19","volume":"2087","author":"N Tamassia","year":"2020","unstructured":"Tamassia, N., Cassatella, M. A. & Bazzoni, F. Fast and Accurate Quantitative Analysis of Cytokine Gene Expression in Human Neutrophils by Reverse Transcription Real-Time PCR. Methods Mol. Biol. 2087, 243\u2013260 (2020).","journal-title":"Methods Mol. Biol."},{"key":"58859_CR55","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1016\/j.clml.2015.07.457","volume":"15","author":"C. Giallongo","year":"2015","unstructured":"Giallongo, C. et al. Granulocyte-like Myeloid Derived Suppressor Cells (G-MDSCs) are increased in Multiple Myeloma due to immunological dysregulation of mesenchymal stem cells (MSCs). Clinical Lymphoma Myeloma and Leukemia, 15, e211.","journal-title":"Clinical Lymphoma Myeloma and Leukemia"},{"key":"58859_CR56","doi-asserted-by":"crossref","unstructured":"Ramachandran, I. R. et al. Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone Marrow. The Journal of Immunology (2013).","DOI":"10.4049\/jimmunol.1203373"},{"key":"58859_CR57","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fonc.2014.00348","volume":"4","author":"C Botta","year":"2014","unstructured":"Botta, C., Gulla, A., Correale, P., Tagliaferri, P. & Tassone, P. Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities. Front. Oncol. 4, 348 (2014).","journal-title":"Front. Oncol."},{"key":"58859_CR58","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/j.1365-3083.2010.02463.x","volume":"72","author":"MK Brimnes","year":"2010","unstructured":"Brimnes, M. K. et al. Increased level of both CD4+FOXP3+ regulatory T cells and CD14+HLA-DR-\/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma. Scand. J. Immunol. 72, 540\u2013547 (2010).","journal-title":"Scand. J. Immunol."},{"key":"58859_CR59","doi-asserted-by":"publisher","first-page":"e1047580","DOI":"10.1080\/2162402X.2015.1047580","volume":"4","author":"B Castella","year":"2015","unstructured":"Castella, B. et al. Anergic bone marrow Vgamma9Vdelta2 T cells as early and long-lasting markers of PD-1-targetable microenvironment-induced immune suppression in human myeloma. Oncoimmunology 4, e1047580 (2015).","journal-title":"Oncoimmunology"},{"key":"58859_CR60","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.3109\/10428194.2014.904511","volume":"55","author":"J Favaloro","year":"2014","unstructured":"Favaloro, J. et al. Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma. Leukemia lymphoma 55, 2893\u20132900 (2014).","journal-title":"Leukemia lymphoma"},{"key":"58859_CR61","first-page":"198539","volume":"2014","author":"A Romano","year":"2014","unstructured":"Romano, A. et al. Immunological dysregulation in multiple myeloma microenvironment. BioMed. Res. Int. 2014, 198539 (2014).","journal-title":"BioMed. Res. Int."},{"key":"58859_CR62","doi-asserted-by":"crossref","unstructured":"Netherby, C. S. et al. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production. Journal of immunology (Baltimore, Md.: 1950) (2017).","DOI":"10.4049\/jimmunol.1601722"},{"key":"58859_CR63","doi-asserted-by":"crossref","unstructured":"Nachmany, I. et al. The transcriptional profile of circulating myeloid derived suppressor cells correlates with tumor development and progression in mouse. Genes & Immunity (2019).","DOI":"10.1038\/s41435-019-0062-3"},{"key":"58859_CR64","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1182\/blood-2012-07-442541","volume":"121","author":"DA Mancardi","year":"2013","unstructured":"Mancardi, D. A. et al. The high-affinity human IgG receptor Fc\u03b3RI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy. Blood 121, 1563\u20131573 (2013).","journal-title":"Blood"},{"key":"58859_CR65","doi-asserted-by":"crossref","first-page":"43992","DOI":"10.18632\/oncotarget.6083","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells. Oncotarget 6, 43992\u201344004 (2015).","journal-title":"Oncotarget"},{"key":"58859_CR66","doi-asserted-by":"publisher","first-page":"10532","DOI":"10.18632\/oncotarget.3300","volume":"6","author":"K De Veirman","year":"2015","unstructured":"De Veirman, K. et al. Multiple myeloma induces Mcl-1 expression and survival of myeloid-derived suppressor cells. Oncotarget 6, 10532\u201310547 (2015).","journal-title":"Oncotarget"},{"key":"58859_CR67","doi-asserted-by":"publisher","first-page":"85764","DOI":"10.18632\/oncotarget.7969","volume":"7","author":"C Giallongo","year":"2016","unstructured":"Giallongo, C. et al. Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC). Oncotarget 7, 85764\u201385775 (2016).","journal-title":"Oncotarget"},{"key":"58859_CR68","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1042\/BJ20100960","volume":"433","author":"J Kotthaus","year":"2011","unstructured":"Kotthaus, J. et al. Reduction of N(omega)-hydroxy-L-arginine by the mitochondrial amidoxime reducing component (mARC). Biochem. J. 433, 383\u2013391 (2011).","journal-title":"Biochem. J."},{"key":"58859_CR69","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1182\/blood.V79.3.735.735","volume":"79","author":"MA Amezaga","year":"1992","unstructured":"Amezaga, M. A., Bazzoni, F., Sorio, C., Rossi, F. & Cassatella, M. A. Evidence for the involvement of distinct signal transduction pathways in the regulation of constitutive and interferon gamma-dependent gene expression of NADPH oxidase components (gp91-phox, p47-phox, and p22-phox) and high-affinity receptor for IgG (Fc gamma R-I) in human polymorphonuclear leukocytes. Blood 79, 735\u2013744 (1992).","journal-title":"Blood"},{"key":"58859_CR70","doi-asserted-by":"crossref","first-page":"22079","DOI":"10.1016\/S0021-9258(18)54534-8","volume":"266","author":"MA Cassatella","year":"1991","unstructured":"Cassatella, M. A. et al. Interferon-gamma transcriptionally modulates the expression of the genes for the high affinity IgG-Fc receptor and the 47-kDa cytosolic component of NADPH oxidase in human polymorphonuclear leukocytes. J. Biol. Chem. 266, 22079\u201322082 (1991).","journal-title":"J. Biol. Chem."},{"key":"58859_CR71","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/0006-291X(90)92131-I","volume":"170","author":"MA Cassatella","year":"1990","unstructured":"Cassatella, M. A. et al. Interferon gamma induces in human neutrophils and macrophages expression of the mRNA for the high affinity receptor for monomeric IgG (Fc gamma R-I or CD64). Biochem. Biophys. Res. Commun. 170, 582\u2013588 (1990).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"58859_CR72","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1172\/JCI88169","volume":"128","author":"Y Kawano","year":"2018","unstructured":"Kawano, Y. et al. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. J. Clin. Invest. 128, 2487\u20132499 (2018).","journal-title":"J. Clin. Invest."},{"key":"58859_CR73","first-page":"1444","volume":"25","author":"ZJ Xu","year":"2017","unstructured":"Xu, Z. J. et al. [Levels of T-Lymphocyte Subsets, IL-17, IL-35 and IFN-gamma in Peripheral Blood and Their Clinical Significance in Patients with Multiple Myeloma]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 25, 1444\u20131448 (2017).","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"key":"58859_CR74","doi-asserted-by":"crossref","unstructured":"Bailur, J. K. et al. Early alterations in stem-like\/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy. JCI Insight, 5 (2019).","DOI":"10.1172\/jci.insight.127807"},{"key":"58859_CR75","first-page":"282","volume":"13","author":"DR Jacobson","year":"1986","unstructured":"Jacobson, D. R. & Zolla-Pazner, S. Immunosuppression and infection in multiple myeloma. Semin. Oncol. 13, 282\u2013290 (1986).","journal-title":"Semin. Oncol."},{"key":"58859_CR76","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/1078155211412842","volume":"18","author":"CA Dasanu","year":"2012","unstructured":"Dasanu, C. A. Immune alterations in untreated and treated multiple myeloma. J. Oncol. Pharm. Pract. 18, 257\u2013263 (2012).","journal-title":"J. Oncol. Pharm. Pract."},{"key":"58859_CR77","first-page":"2927","volume-title":"Journal of immunology (Baltimore, Md.: 1950)","author":"CW Yang","year":"2010","unstructured":"Yang, C. W., Strong, B. S., Miller, M. J. & Unanue, E. R. Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants. Journal of immunology (Baltimore, Md.: 1950) 185, (2927\u20132934 (2010)."},{"issue":"Suppl 7","key":"58859_CR78","doi-asserted-by":"publisher","first-page":"S408","DOI":"10.1086\/431990","volume":"41","author":"J Texereau","year":"2005","unstructured":"Texereau, J. et al. The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin. Infect. Dis. 41(Suppl 7), S408\u2013415 (2005).","journal-title":"Clin. Infect. Dis."},{"key":"58859_CR79","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.tube.2018.06.010","volume":"111","author":"J Nancy Hilda","year":"2018","unstructured":"Nancy Hilda, J. & Das, S. Neutrophil CD64, TLR2 and TLR4 expression increases but phagocytic potential decreases during tuberculosis. Tuberculosis. 111, 135\u2013142 (2018).","journal-title":"Tuberculosis."},{"key":"58859_CR80","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.exphem.2016.01.002","volume":"44","author":"S Wichert","year":"2016","unstructured":"Wichert, S., Pettersson, A., Hellmark, T., Johansson, A. & Hansson, M. Phagocyte function decreases after high-dose treatment with melphalan and autologous stem cell transplantation in patients with multiple myeloma. Exp. Hematol. 44, 342\u2013351.e345 (2016).","journal-title":"Exp. Hematol."},{"key":"58859_CR81","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1182\/blood-2009-04-216085","volume":"115","author":"M Pelletier","year":"2010","unstructured":"Pelletier, M. et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115, 335\u2013343 (2010).","journal-title":"Blood"},{"key":"58859_CR82","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1038\/s41590-019-0514-y","volume":"20","author":"X Li","year":"2019","unstructured":"Li, X., Bechara, R., Zhao, J., McGeachy, M. J. & Gaffen, S. L. IL-17 receptor-based signaling and implications for disease. Nat. Immunol. 20, 1594\u20131602 (2019).","journal-title":"Nat. Immunol."},{"key":"58859_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07305-8","volume":"9","author":"A Calcinotto","year":"2018","unstructured":"Calcinotto, A. et al. Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression. Nat. Commun. 9, 4832 (2018).","journal-title":"Nat. Commun."},{"key":"58859_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39672-7","volume":"9","author":"T Bagratuni","year":"2019","unstructured":"Bagratuni, T. et al. Toll-Like Receptor 4 Activation Promotes Multiple Myeloma Cell Growth and Survival Via Suppression of The Endoplasmic Reticulum Stress Factor Chop. Sci. Rep. 9, 3245 (2019).","journal-title":"Sci. Rep."},{"key":"58859_CR85","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2141.2010.08284.x","volume":"150","author":"Y Xu","year":"2010","unstructured":"Xu, Y. et al. Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-kappaB. Br. J. haematology 150, 543\u2013553 (2010).","journal-title":"Br. J. haematology"},{"key":"58859_CR86","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.4049\/jimmunol.1002514","volume":"187","author":"B Castella","year":"2011","unstructured":"Castella, B. et al. Immune modulation by zoledronic acid in human myeloma: an advantageous cross-talk between Vgamma9Vdelta2 T cells, alphabeta CD8+ T cells, regulatory T cells, and dendritic cells. Journal of immunology (Baltimore, Md.: 1950) 187, 1578\u20131590 (2011).","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"key":"58859_CR87","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3324\/haematol.2014.105866","volume":"99","author":"M Foglietta","year":"2014","unstructured":"Foglietta, M. et al. The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status. Haematologica 99, 1605\u20131610 (2014).","journal-title":"Haematologica"},{"issue":"6","key":"58859_CR88","doi-asserted-by":"publisher","first-page":"e1008850","DOI":"10.1080\/2162402X.2015.1008850","volume":"4","author":"Arianna Calcinotto","year":"2015","unstructured":"Calcinotto, A. et al. Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma. Oncoimmunology, 4 (2015).","journal-title":"OncoImmunology"},{"key":"58859_CR89","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1182\/bloodadvances.2017005447","volume":"1","author":"CM Ho","year":"2017","unstructured":"Ho, C. M. et al. Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT. Blood Adv. 1, 1056\u20131066 (2017).","journal-title":"Blood Adv."},{"key":"58859_CR90","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/00024382-200116020-00003","volume":"16","author":"M Hirsh","year":"2001","unstructured":"Hirsh, M., Mahamid, E., Bashenko, Y., Hirsh, I. & Krausz, M. M. Overexpression of the high-affinity Fcgamma receptor (CD64) is associated with leukocyte dysfunction in sepsis. Shock. 16, 102\u2013108 (2001).","journal-title":"Shock."},{"key":"58859_CR91","doi-asserted-by":"publisher","first-page":"202646","DOI":"10.1155\/2008\/202646","volume":"2008","author":"M Groselj-Grenc","year":"2008","unstructured":"Groselj-Grenc, M., Ihan, A. & Derganc, M. Neutrophil and monocyte CD64 and CD163 expression in critically ill neonates and children with sepsis: comparison of fluorescence intensities and calculated indexes. Mediators Inflamm. 2008, 202646 (2008).","journal-title":"Mediators Inflamm."},{"key":"58859_CR92","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/PEC.0b013e31818c2679","volume":"24","author":"B Rudensky","year":"2008","unstructured":"Rudensky, B., Sirota, G., Erlichman, M., Yinnon, A. M. & Schlesinger, Y. Neutrophil CD64 expression as a diagnostic marker of bacterial infection in febrile children presenting to a hospital emergency department. Pediatric Emerg. care 24, 745\u2013748 (2008).","journal-title":"Pediatric Emerg. care"},{"key":"58859_CR93","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/gene.2013.22","volume":"14","author":"EN Rogers","year":"2013","unstructured":"Rogers, E. N. et al. Toll-like receptor-associated sequence variants and prostate cancer risk among men of African descent. Genes. Immun. 14, 347\u2013355 (2013).","journal-title":"Genes. Immun."},{"key":"58859_CR94","first-page":"R6","volume":"11","author":"Y Li","year":"2009","unstructured":"Li, Y. et al. Increased expression of FcgammaRI\/CD64 on circulating monocytes parallels ongoing inflammation and nephritis in lupus. Arthritis Res. Ther. 11, R6\u2013R6 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"58859_CR95","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W Huang da","year":"2009","unstructured":"Huang da, W., Sherman, B. T. & Lempicki, R. A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44\u201357 (2009).","journal-title":"Nat. Protoc."},{"key":"58859_CR96","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1038\/leu.2015.124","volume":"29","author":"E Morelli","year":"2015","unstructured":"Morelli, E. et al. Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo. Leukemia 29, 2173\u20132183 (2015).","journal-title":"Leukemia"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58859-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58859-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58859-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T15:09:09Z","timestamp":1672672149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58859-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,6]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58859"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58859-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,6]]},"assertion":[{"value":"25 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1983"}}